There were 1.6 million people living with HIV in Kenya in 2016. Only 64% of adults living with HIV are on antiretroviral treatment. Infections are particularly high among marginalised groups such as men who have sex with men (MSM), sex workers and people who use drugs.

We partner with KANCO, a network of indigenous Kenyan organisations working not just on the HIV response, but across public health care in Kenya. KANCO works to strengthen its member organisations, improve community responses to HIV, and integrate HIV and TB services. In 2017, KANCO provided over 8,000 people with TB services.

In Kenya, there are an estimated 18,000 people who inject drugs. Through the Community Action on Harm Reduction programme, KANCO implemented Kenya’s first ever needle and syringe exchange and methadone replacement programme. KANCO are continuing this work as the principal recipient for the Global Fund Regional Grant for Harm Reduction in Eastern Africa. They are also working on the Alliance’s Integrated Harm Reduction Programme, and provided 12,268 people who use drugs with prevention services in 2017.

KANCO provided 32,886 people with integrated HIV and SRHR services in 2017. KANCO are also partners on the PITCH programme, which aims to develop the capacity of civil society organisations to advocate for improved access to HIV prevention, care and treatment services.